Nonalcoholic fatty liver disease in menopausal women;Doença hepática gordurosa não alcoólica em mulheres meno-pausadas

Arquivos de Gastroenterologia

Volumn 50, Issue 3, 2013, Pages 180-185

  Florentino, Gesira Soares de Assis ^a,b   Cotrim, Helma Pinchemel ^a   Vilar, Consuelo Padilha ^a,b   Florentino, André Vinícius de Assis ^c   Guimarães, Geruza Maria Almeida ^b   Barreto, Victorino Spinelli Toscano ^d  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^b FEDERAL UNIVERSITY OF CAMPINA GRANDE   (Brazil)

^c Médicas de Campina Grande   (Brazil)

^d Instituto Do Figado and Transplants of Pernambuco   (Brazil)

Author keywords

Fatty liver; Hormone replacement therapy

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; ESTROGEN; FERRITIN; GAMMA GLUTAMYLTRANSFERASE; TIBOLONE;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEPATITIS; HORMONE SUBSTITUTION; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MENOPAUSE; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; OBESITY; PREVALENCE; STEATOSIS;

ANALYSIS OF VARIANCE; CROSS-SECTIONAL STUDIES; ESTROGEN REPLACEMENT THERAPY; FATTY LIVER; FEMALE; HUMANS; INSULIN RESISTANCE; METABOLIC SYNDROME X; MIDDLE AGED; POSTMENOPAUSE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SOCIOECONOMIC FACTORS;

EID: 84885038006     PISSN: 00042803     EISSN: 16784219     Source Type: Journal    
DOI: 10.1590/S0004-28032013000200032     Document Type: Article

References (27)

1. Arkin H, Colton R. Tables for statisticians. New York: Barnes & Noble, 1959.
2. Canderelli R, Leccesse LA, Miller NL, Unruh Davidson J. Benefits of hormone replacement therapy in postmenopausal women. J Am Acad Nurse Pract. 2007;19:635-641.
3. Clark JM. The epidemiology of nonalcoholic fatty liver disease in adults. J Clin Gastroenterol.2006;40:S5-S10.
4. Codes L, Asselah T, Cazals-Hatem D, Tubach F, Vidaud D, Paraná R, Bedossa P, Bedossa P, Valla D, Marcellin P. Liver fibrosis in women with chronic hepatitis C: evidence for the negative role of the menopause and steatosis and the potential benefit of hormone replacement therapy. Gut 2007;56:390-395.
5. Coral G, de Mattos AA, de Mattos AZ, dos Santos DE. [Steatosis and non-alcoholic steatohepatitis in patients with chronic hepatitis due to hepatitis C virus infection]. Arq Gastroenterol. 2006;43:265-268.
6. Corriveau P, Paquette A, Brochu M, Prud'homme D, Rabasa-Lhoret R, Lavoie JM. Resistance training prevents liver fat accumulation in ovariectomized rats. Maturitas 2008;59:259-267.
7. De Moura Almeida A, Cotrim HP, Barbosa DB, de Athayde LG, Santos AS, Bitencourt AG, de Freitas LA, Rios A, Alves E. Fatty liver disease in severe obese patients: diagnostic value of abdominal ultrasound. World J Gastroenterol. 2008;14:1415-1418.
8. Di Martino V, Lebray P, Myers RP, Pannier E, Paradis V, Charlotte F, Moussalli J, Thabut D, Buffet C, Poynard T. Progression of liver fbrosis in women infected with hepatitis C: long-term beneft of estrogens exposure. Hepatology 2004;40:1426-1433.
9. Gervais A, Bacq Y, Bernuau J, Martinot M, Auperin A, Boyer N, Kilani A, Erlinger S, Valla D, Marcellin P. Decrease in serum ALT and increase in serum HCV RNA during pregnancy in women with chronic hepatitis C. J Hepatol. 2000;32:293-299.
10. Gutierrez-Grobe Y, Ponciano-Rodríguez G, Ramos MH, Uribe M, Méndez-Sán-chez N. Prevalence of non alcoholic fatty liver disease in premenopausal, pos-menopausal and polycystic ovary syndrome women: the role of estrogens. Ann Hepatol. 2010;9:402-409.
11. Hamaguchi M, Kojima T, Ohbora A, Takeda N, Fukui M, Kato T. Aging is a risk factor of nonalcoholic fatty liver disease in premenopausal women. World J Gastroenterol. 2012;18:237-243.
12. Karnikowski M, Córdova C, Oliveira RJ, Karnikowski MG, Nóbrega O Det. Non-alcoholic fatty liver disease and metabolic syndrome in Brazilian middle-aged and older adults. Sao Paulo Med J. 2007;125:333-337.
13. Lavoie JM, Pighon A. NAFLD, estrogens, and physical exercise: the Animal Model. J Nutr Metab. 2012;2012:914-938.
14. Marfell-Jones M. International standards for anthropometric assessment. Rev. ed. Potchefstroom, South Africa: International Society for the Advancement of Kinanthropometry. 2006.
15. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419.
16. McKenzie J, Fisher BM, Jaap AJ, Stanley A, Paterson K, Sattar N. Effects of HRT on liver enzyme levels in women with type 2 diabetes: a randomized placebo-controlled trial. Clin Endocrinol. 2006;65:40-44.
17. Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfeld SB. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med. 2003;163:427-436.
18. Rosa-e-Silva AC, Melo AS. A importância da via de administração na terapia hormonal do climatério. Femina 2010;38:279-285.
19. Shimizu I, Ito S. Protection of estrogens against the progression of chronic liver disease. Hepatol Res. 2007;37:239-247.
20. Sitruk-Ware R, Plu-Bureau G, Menard J, Conard J, Kumar S, Thalabard JC, Tokay B, Bouchard P. Effects of oral and transvaginal ethinyl estradiol on hemostatic factors and hepatic proteins in a randomized, crossover study. J Clin Endocrinol Metab. 2007;92:2074-2079.
21. Suzuki A, Abdelmalek MF. Nonalcoholic fatty liver disease in women. Womens Health 2009;5:191-203.
22. Villa E, Karampatou A, Cammà C, Di Leo A, Luongo M, Ferrari A, Petta S, Losi L, Taliani G, Trande P, Lei B, Graziosi A, Bernabucci V, Critelli R, Pazienza P, Rendina M, Antonelli A, Francavilla A. Early menopause is associated with lack of response to antiviral therapy in women with chronic hepatitis C. Gastro-enterology 2011;140:818-829.
23. Walsh B W, Li H, Sacks FM. Effects of postmenopausal hormone replacement with oral and transdermal estrogen on high density lipoprotein metabolism. J Lipid Res. 1994;35:2083-2093.
24. Wieckowska A, Feldstein AE. Diagnosis of nonalcoholic fatty liver disease: invasive versus noninvasive. Semin Liver Dis. 2008;28:386-395.
25. Wren BG. The benefts of oestrogen following menopause: why hormone replacement therapy should be offered to postmenopausal women. Med J Aust. 2009;190:321-325.
26. Yasuda M, Shimizu I, Shiba M, Ito S. Suppressive effects of estradiol on dimeth-ylnitrosamine-induced fbrosis of the liver in rats. Hepatology 1999;29:719-727.
27. Yatsuji S, Hashimoto E, Tobari M, Tokushige K, Shiratori K. Influence of age and gender in Japanese patients with non-alcoholic steatohepatitis. Hepatol Res. 2007;37:1034-1043.